Um homem de meia-idade, com um fato escuro de riscas, camisa azul clara e gravata às riscas, sorri para a câmara num ambiente moderno de um escritório de advogados.

Michael J. Tuteur

Sócio/Reformado

Michael J. Tuteur

Sócio/Reformado

Mike Tuteur passou quase 40 anos a defender com sucesso casos e a argumentar recursos em tribunais civis e criminais em todo o país. É procurado pelo seu julgamento experiente, experiência em julgamentos e vitórias em litígios. Mike atuou como presidente do Departamento Nacional de Contencioso da empresa de 2009 a 2015, bem como presidente da sua Prática de Contencioso Comercial. Ele é sócio da Prática de Defesa e Investigação de Execução Governamental e ex-membro do Comité de Gestão nacional da empresa.

Mike represents a broad range of clients, with a particular focus on health care litigation, False Claims Act defense, government and internal investigations, and scientific and research misconduct. He has recently been involved in FCA matters involving Medicare Advantage as well as assisting various health care entities, including “High Impact Target” hospitals, avoiding FCA liability in connection with the CARES Act, the Paycheck Protection Program, and the Health Care Enhancement Act.

Mike’s extensive experience includes ERISA and RICO class actions, False Claims Act (FCA) litigation, and the defense of both organizations and individuals in Justice Department and SEC investigations. He is particularly skilled in investigating and defending academic institutions in connection with claims of scientific misconduct and research misconduct. And he was named “Lawyer of the Year” in Boston for Bet-the-Company Litigation in both 2018 and 2020 by Best Lawyers in America.

Earlier in his career, Mike served as an Assistant U.S. Attorney in the Major Crimes and Organized Crime Strike Force units of the U.S. Attorney’s office in Boston. Between his prosecutorial experience and his private practice, Mike has tried more than 20 cases to decision. He has also argued nearly 20 appeals in state and federal appellate courts across the country.

Mike has been appointed a Special Assistant Attorney General on several occasions, including four appointments to represent Massachusetts Govs. William F. Weld and A. Paul Cellucci in constitutional cases involving the scope and effect of the governor’s veto power. A U.S. District Judge appointed Mike to investigate allegations of document destruction and attorney misconduct. Mike also served as an expert witness to the Royal Courts of Justice in London to give opinion evidence on the application of U.S. law to the Latin American syndicated debt market.

“He’s a terrific, standout lawyer and very intelligent,” according to Chambers & Partners, USA. “His experience, his writing and his judgment are all strong.”

Mike received his A.B. from Harvard College, summa cum laude, and his J.D. from Harvard Law School, magna cum laude. He now serves as a trial adviser at Harvard Law School’s Trial Advocacy Workshop and judges its Ames Moot Court program. He also has taught at the Harvard School of Public Health’s Continuing Education Program on Corporate Compliance and is a frequent writer and speaker on civil and criminal jurisprudence, with a special emphasis on the law of research and scientific misconduct.

Mike has devoted significant time to litigating special education cases on a pro bono basis. He has helped make new law in the First Circuit on behalf of special needs families who have been forced by financial constraints to leave their place of residence. For his pro bono work, the Massachusetts Supreme Judicial Court’s Standing Committee on Pro Bono Legal Services awarded Mike its Certificate of Recognition in 2007.

Mike is a member and former chair of the Advisory Board of the Smithsonian Astrophysical Observatory, a component of the Center for Astrophysics | Harvard & Smithsonian and serves on the Smithsonian New England Regional Council.

Prémios e reconhecimentos

  • Named Best Lawyers® 2018 and 2020 Bet-the-Company Litigation “Lawyer of the Year” in Boston
  • Selecionado pelos seus pares para inclusão na Os melhores advogados daAmérica® nos domínios de:
    • Bet-the-Company Litigation (2010-2024)
    • Commercial Litigation (2007, 2010-2024)
    • Criminal Defense: White-Collar (2007, 2011, 2013-2023)
    • Health Care Law (2018-2023)
  • Reconhecido em Chambers USA: America's Leading Lawyers for Business in the practice areas of:
    • Litigation: General Commercial (2004-2024)
    • Litigation: White-Collar Crime & Government Investigations (2004-2015)
  • Top 100 Massachusetts Super Lawyers® (2004-present)

Apresentações e publicações

  • Co-author, “The 25th Anniversary of the Business Litigation Session: A Look Back,” Boston Bar Journal (Fall 2024)
  • Coautor, "Ensaios Clínicos Descentralizados: Research Misconduct Risks & How to Avoid Them," Health Care Law Today (30 de setembro de 2024)
  • Coautor, “Medicare Advantage: Um Tribunal de Circuito Aborda o que é (ou não é) relevante em casos relacionados à Lei de Reivindicações Falsas”, Health Care Law Today (18 de setembro de 2024)
  • Co-author, “Business Litigation Session 2023 Year in Review,” Mass. Lawyers Weekly.
  • Author, “‘Let’s Talk Compliance’: Medicare Advantage: Compliance Issues and Enforcement” Health Care Law Today (March 12, 2024)
  • Co-author, “HRSA Uninsured Program COVID-19 Services: What Were the Standards to Determine Uninsured Status?” The National Law Review (August 17, 2023)
  • Speaker, “Supreme Court’s EPA Ruling Jeopardizes Healthcare Regulations,” Modern Healthcare (July 12, 2022)
  • Co-author, “Massachusetts Business Litigation Session,” American Bar Association Recent Developments in Business Courts 2022 (February 2, 2022)
  • Co-author, “Protecting Your Institution from False Claims Act Allegations After Receipt of CARES Act Funding,” American Health Law Association (November 11, 2020)
  • Co-author, “Year in review: the Business Litigation Session, 2019,” Massachusetts Lawyers Weekly (January 2020)
  • Co-author, “Provisional Remedies,” Practical Law (October 2019)
  • Co-author, “Commencing an Action: Massachusetts,” Practical Law (April 2019)
  • Panelist/speaker: The Business Litigation Session: Year in Review 2018, presented by Social Law Library and Mass. Lawyers Weekly (January 2019)
  • Co-author, “That ‘Hot’ Research Project May Land Your Lab in Hot Water,” Compliance Today (November 2018)
  • Co-author, “Responding to a Complaint: Massachusetts,” Practical Law (November 2018)
  • Co-author, “Q&A Litigation Overview: Massachusetts,” Practical Law (October 2018)
  • Panelist, “Government Sponsored Research, Research Integrity, and the False Claims Act,” ABA National Institute to the Civil False Claims Act (June 2018)
  • Panelist, “Understanding the Difference Between Scientific Research, Misconduct and Fraud,” ACC (June 19, 2018)
  • Co-author, “Scientific research misconduct vs. fraud: How to tell the difference.” Compliance Today (May 2018)
  • Co-author, “The Business Litigation Session Year in Review,” Massachusetts Lawyers Weekly (January 4, 2018)
  • Speaker, “Exhibit (Facebook): The Impact of Social Media on Civil Litigation,” Boston Bar Association (October 6, 2016)
  • Speaker, “Use and Misuse of ERISA in Out-of-Network Litigation,” Blue Cross Blue Shield Summit (May 17, 2016)
  • Speaker, “World Recognition of Distinguished General Counsel,” The Directors Roundtable (February 2, 2014)
2 de julho de 2025 Pro Bono

Foley obtém vitória pro bono, permitindo a graduação de estudante de educação especial

Foley & Lardner LLP garantiu uma vitória pro bono ao obter apoio educacional fundamental para um estudante de educação especial. Como resultado da intervenção de Foley e do litígio iniciado sete anos antes, o cliente pôde recentemente obter um diploma do ensino secundário e participar nas cerimónias de início de curso.
Um conjunto de tubos de ensaio com líquido azul dispostos numa prateleira branca sobre uma mesa de laboratório, rodeados por outros utensílios de vidro, evoca a precisão frequentemente encontrada em escritórios de advocacia especializados em propriedade intelectual.
September 30, 2024 Health Care Law Today

Decentralized Clinical Trials: Research Misconduct Risks & How to Avoid Them

The COVID-19 Pandemic required the health care industry to adapt to accommodate remote patient care, including for patients involved in clinical trials, and the use of Decentralized Clinical Trials proliferated during the Pandemic.
24 de setembro de 2024 A lei da saúde hoje

Conduta imprópria na investigação: ORI publica regulamento final com regras modernizadas e simplificadas

Em 17 de setembro de 2024, o Gabinete de Integridade da Investigação (ORI) emitiu uma regra final adotando alterações aos regulamentos federais que regem a má conduta em investigações financiadas pelo governo federal (Regra Final).
Close-up de um clipe de papel prendendo um cartão do Medicare e documentos, com a palavra «Medicare» claramente visível — uma imagem frequentemente vista em escritórios de advocacia corporativa ou entre advogados em Chicago que lidam com informações confidenciais de clientes.
18 de setembro de 2024 A lei da saúde hoje

Medicare Advantage: Um Tribunal de Circuito aborda o que é (ou não é) relevante em casos relacionados à Lei de Reivindicações Falsas

Em 13 de setembro de 2024, o Tribunal de Apelações dos Estados Unidos para o Oitavo Circuito publicou a sua tão esperada decisão no caso United States ex rel. Holt v. Medicare Medicaid Advisors, confirmando a rejeição do Distrito Ocidental do Missouri de um caso Medicare Advantage — uma vitória para as partes interessadas em cuidados de saúde geridos, especialmente seguradoras, corretores de seguros e organizações de comercialização de seguros.
6 de junho de 2024 Comunicados de imprensa

Foley obtém as melhores classificações na Chambers USA 2024

Foley & Lardner LLP tem o prazer de anunciar que foi novamente reconhecido pela Chambers & Partners como um dos principais escritórios de advocacia do país na edição de 2024 da Chambers USA, America's Leading Lawyers for Business.
Um estetoscópio repousa sobre uma folha de papel com gráficos de barras e linhas azuis, sugerindo uma ligação entre a análise de dados de saúde e o apoio em litígios em escritórios de advocacia.
12 de março de 2024 A lei da saúde hoje

“Let’s Talk Compliance”: Medicare Advantage: Compliance Issues and Enforcement

During Session 3 of the Let’s Talk Compliance series, PYA principal Valerie Rock and Foley and Lardner partner Michael Tuteur spoke about the changing landscape related to government scrutiny and oversight around Medicare Advantage (MA) plans and their payments.